Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Clinical trial NCT01994889 · COMPLETED

Trial details

NCT number: NCT01994889
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Transthyretin (TTR) Amyloid Cardiomyopathy

Start date: 2013-12-09
Primary completion: 2018-02-07
Enrollment: 441

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.